Gain Therapeutics, Inc.GANXNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank67
3Y CAGR-34.5%
5Y CAGR+102.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-34.5%/yr
Annual compound
5Y CAGR
+102.7%/yr
Recent deceleration
Percentile
P67
Within normal range
vs 5Y Ago
34.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $10.39M | -11.9% |
| 2023 | $11.79M | +61.3% |
| 2022 | $7.31M | -80.2% |
| 2021 | $36.88M | +392.2% |
| 2020 | $7.49M | +2370.3% |
| 2019 | $303320.00 | -24.3% |
| 2018 | $400694.00 | - |